Concetta Forchetti, MD
Neurology · Elk Grove Village, ILNPI 1184656852
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $118,445 of the $168,979 with a category attached, or 70.1%. 10 manufacturers reported payments, led by Lilly USA, LLC at 51.0% of the total. 2025 is the largest year on record at $50,288, 6.2 times the $8,113 reported in 2019. Among neurology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 165 payments — averaging $1024.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$86K
- Biogen$46K
- Eisai Inc.$19K
- Eli Lilly$9K
- Merck$7K
- Life Molecular Imaging Ltd$600
- plus $230 from 4 others
Across 491 payments — averaging $17,069 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$3.5M
- Eli Lilly$2.8M
- Genentech, Inc.$766K
- Janssen Research & Development, LLC$510K
- Novartis$274K
- GSK$230K
- plus $239K from 4 others
What the payments were for
- Consulting fees$41,53025%
- Speaking & faculty fees$118,44570%
- Travel & lodging$6,4534%
- Food & beverage$2,5111%
- Education$400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 104 | $86,156 |
| Biogen | 37 | $45,743 |
| Eisai Inc. | 10 | $19,410 |
| Eli Lilly | 7 | $9,431 |
| Merck | 1 | $7,410 |
| Life Molecular Imaging Ltd | 1 | $600 |
| Otsuka America Pharmaceutical, Inc. | 1 | $119 |
| Genentech, Inc. | 1 | $40 |
| Boston Scientific | 2 | $40 |
| Bristol Myers Squibb | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$168,979 in reported general payments places this provider in the 95th percentile of 790 neurology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Donepezil Hcl | 494 | $5,388 |
| Escitalopram Oxalate | 352 | $3,898 |
| Galantamine Hbr | 13 | $1,993 |
| Memantine Hcl | 78 | $1,941 |
| Quetiapine Fumarate | 101 | $1,667 |
| Alprazolam | 33 | $274 |
| Lorazepam | 23 | $166 |
| Clonazepam | 19 | $126 |
| Citalopram HbrCitalopram Hydrobromide | 13 | $80 |
Paid to pharmacies, not to this prescriber.
Other neurology in Elk Grove Village
- Scott GeraghtyElk Grove Village$111K
- Augusto MiravalleChicago$1.4M
- Lori GuytonHerrin$1.1M
- Daniel WynnNorthbrook$812K
- Arthur ItkinPalos Heights$808K
- Andrew GordonLake Barrington$765K
- Martha McGrawWinfield$625K
- Reuben ValenzuelaPeoria$590K
- Adil JavedChicago$584K
- Tyler KaplanMaywood$549K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.